| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;116:e64-e67.)
© 2007 American Heart Association, Inc.
AHA Conference Proceedings |
Key Words: AHA Conference Proceedings myocardial infarction point-of-care systems angioplasty reperfusion
| Introduction |
|---|
|
|
|---|
| Conceptual Model for Evaluation |
|---|
|
|
|---|
Structure
Structure refers to component personnel, equipment, and facilities needed to provide ideal STEMI care. At this conference, several model systems provided examples of EMS, emergency department, percutaneous coronary intervention (PCI)–capable hospital, and regional network features associated with improved reperfusion times (Table 1). Although "structure often drives function," these structural features should be used only as a guide and will often need to be individualized for a particular care setting. Many of these features are described elsewhere in this report, yet 2 require further explanation. First, we believe that providers should participate in national data collection and quality improvement programs. Examples of such programs include those for EMS,3 myocardial infarction,4–6 and PCI.7 Participation in such programs provides caregivers with standardized tools for data collection and risk adjustment, as well as feedback on how their care compares with peers. Such feedback systems are known to be a critical element in continuous quality improvement.8
|
As regional STEMI care delivery systems mature, the model of an individual hospital-centered quality improvement program will need to expand to that of collaborative, community-wide oversight programs. These may include a regional STEMI steering committee and, potentially, a separate data safety monitoring board. Such oversight should have comprehensive representation that includes the regions EMS director and EMS medical director, other emergency services leaders (fire and police), representatives from both the STEMI referral and STEMI-receiving hospitals, and regional medical and professional society representatives. These committees should share provider process and outcome data in a transparent manner to ensure access and quality of STEMI care.
Process
Process refers to actions performed in the delivery of care to a patient, including timing and technical competency. Table 2 provides a list of potential process metrics that could be tracked to ensure quality STEMI care. Several of these relate to the timeliness of key steps in the reperfusion process. From a patient perspective, "total ischemic time" (defined as the time from symptom onset to successful PCI) is the most important interval. Yet, the exact onset of symptoms can often be difficult to define. As such, other more quantifiable, intermediate measures (eg, time from 9-1-1 call to hospital arrival and time from hospital to cardiac catheterization laboratory arrival) are also recommended. Beyond timely reperfusion, the importance of providing all evidence-based care, as outlined in the American College of Cardiology/American Heart Association guidelines, to eligible patients is also stressed.9
|
Outcomes
"Outcomes" refers to tangible measures of the consequences of patient care and can be subdivided into categories of mortality, nonfatal adverse events, and patient-reported health status measures (symptoms, functional status, and quality of life). Outcomes assessment should also consider the impact of care on non–health-related measures such as patient satisfaction and economic implications. Finally, outcomes measures may also consider potential unanticipated consequences of care changes. For instance, widespread use of prehospital ECGs and prehospital activation of the cardiac catheterization laboratory may lead to an increase in emergency coronary angiography among patients without acute coronary occlusion; this may lead to increased costs of care and patient risks due to unnecessary procedures. Similarly, a policy that leads to proliferation of low-volume, "stand-alone" primary PCI centers may ultimately result in more procedural complications. A list of potential outcomes metrics is provided in Table 3.
|
Outcomes represent the aggregate effect of all structure and care processes. Thus, improving this end product is the ultimate goal of successful medical care. The use of outcomes metrics for evaluation, however, also presents challenges. In the case of STEMI care, many adverse events rates tend to be uncommon. Thus, estimates of outcomes performance measures are often unstable at the single-center level, particularly when evaluated over a relatively brief time interval. Moreover, multiple factors beyond provider quality affect patient outcomes and must be accounted for before outcomes comparisons are meaningful. Thus, there is a need for collection of detailed clinical data and rigorous risk adjustment of provider outcomes measurements.10
There are several outcomes perspectives that need to be considered. The first is the time frame for evaluation. Data on acute in-hospital STEMI events are the easiest to collect and most directly related to the care delivered; however, it is also likely that longitudinal patient outcomes (ie, 6 months or 1 year) could be impacted if STEMI care were improved. It is often difficult for providers to collect longitudinal data, yet such data collection may be feasible via collaborations with state quality improvement organizations or other payer partners.
Second, changes in STEMI care may have effects on other areas of cardiac care ("halo effects"). On the positive side, the process integration between emergency medicine and cardiology needed to shorten reperfusion times in primary PCI may also stimulate broader improvements in care for all myocardial infarction patients. On the other hand, if a provider focused solely on reperfusion metrics, this could conceivably distract efforts to improve other evidence-based myocardial infarction care processes.
Finally, one must consider the level of aggregation of results. Currently, the standard paradigm of outcome evaluation is generally centered on individual institutional performance; however, in many STEMI situations, patients require timely transport to a center and even transfer between centers to receive reperfusion. Evaluation of such integrated care systems clearly needs to consider the performance of the system as a whole. For example, if the sickest patients with STEMI never reach the tertiary care center, STEMI outcomes for the community may not improve despite measured improvements at an individual center.
| Patient Satisfaction and Economic Impact |
|---|
|
|
|---|
Increased delivery of primary PCI will likely have multiple direct and indirect economic impacts. First, the overall cost-effectiveness of such programs should be considered from a societal perspective. Such an evaluation will need to consider the fixed costs associated with implementing changes in care (eg, training, equipment, and infrastructure), as well as the variable costs related to the changes themselves (eg, patient transfer and performance of PCI). It is possible (although not assured) that any resulting cost increases may be counterbalanced by savings associated with reduced complications in both the short and long term.
Beyond societal costs, one must also consider the impact of any programmatic changes on the flow of funds at specific institutions. For example, if regionalization results in large shifts in revenue for cardiac care from the local primary care facilities to specialized regional centers, this could have serious adverse consequences on a local hospitals economic viability. Because cardiology care often supports other less-compensated hospital activities, these financial shifts could have broad implications on the health of a community.
| Potential Uses of Evaluative Data |
|---|
|
|
|---|
On a second level, certain STEMI metrics could be made public and used for quality assurance or even to alter provider reimbursement rates ("pay-for-quality" programs). When evaluation measures are tied to financial or nonfinancial incentives, such metrics should meet a higher level of rigor and specificity.11,12 Finally, it must be realized that metrics for evaluating STEMI care will need to evolve as the field evolves. Thus, new therapeutic advances or "out-of-the-box" innovations in care delivery may stimulate a need to reevaluate the tools used in the evaluation process itself.
| Summary |
|---|
|
|
|---|
| Acknowledgments |
|---|
Potential conflicts of interest for members of the writing groups for all sections of these conference proceedings are provided in a disclosure table included with the Executive Summary.
| Footnotes |
|---|
The opinions expressed in this manuscript are those of the authors and should not be construed as necessarily representing an official position of the US Department of Health and Human Services, the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, or the US government. These opinions are not necessarily those of the editor or the American Heart Association.
The Executive Summary for these proceedings is available in the July 10, 2007, issue of Circulation (Circulation. 2007;116:217–230). Writing group reports are available online at http://circ.ahajournals.org (Circulation. 2007;116:e29–e32, e33–e38, e39–e42, e43–e48, e49–e54, e55–e59, e60–e63, e64–e67, e68–e72, and e73–e76).
The publication of these proceedings was approved by the American Heart Association Science Advisory and Coordinating Committee on April 18, 2007. A single reprint of the entire conference proceedings is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0413. To purchase additional reprints, call 843-216-2533 or e-mail kelle.ramsay@wolterskluwer.com.
Expert peer review of AHA Scientific Statements is conducted at the AHA National Center. For more on AHA statements and guidelines development, visit http://www.americanheart.org/presenter.jhtml?identifier=3023366.
Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American Heart Association. Instructions for obtaining permission are located at http://www.americanheart.org/presenter.jhtml?identifier=4431. A link to the "Permission Request Form" appears on the right side of the page.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. H. Ting, H. M. Krumholz, E. H. Bradley, D. C. Cone, J. P. Curtis, B. J. Drew, J. M. Field, W. J. French, W. B. Gibler, D. C. Goff, et al. Implementation and Integration of Prehospital ECGs Into Systems of Care for Acute Coronary Syndrome: A Scientific Statement From the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology Circulation, September 2, 2008; 118(10): 1066 - 1079. [Full Text] [PDF] |
||||
![]() |
B. K. Nallamothu, H. M. Krumholz, D. T. Ko, K. A. LaBresh, S. Rathore, M. T. Roe, and L. Schwamm Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: Gaps, Barriers, and Implications Circulation, July 10, 2007; 116(2): e68 - e72. [Full Text] [PDF] |
||||
![]() |
P. Solis, E. A. Amsterdam, V. Bufalino, B. J. Drew, and A. K. Jacobs Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: Policy Recommendations Circulation, July 10, 2007; 116(2): e73 - e76. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |